Frontiers Current Pharmacological Strategies for Duchenne

Frontiers Current Pharmacological Strategies for Duchenne Muscular Dystrophy

Therapeutic developments for Duchenne muscular dystrophy

Muscle and cardiac therapeutic strategies for Duchenne muscular dystrophy: past, present, and future

Reprogramming RNA processing: an emerging therapeutic landscape: Trends in Pharmacological Sciences

Evaluating the potential of novel genetic approaches for the treatment of Duchenne muscular dystrophy

Recent Therapeutic Advances in Duchenne Muscular Dystrophy (DMD) Models - Aurora Scientific

Frontiers Duchenne muscular dystrophy: disease mechanism and therapeutic strategies

Hypochlorous acid exposure impairs skeletal muscle function and Ca2+ signalling: implications for Duchenne muscular dystrophy pathology - Lea - 2023 - The Journal of Physiology - Wiley Online Library

Cardiorespiratory management of Duchenne muscular dystrophy: emerging therapies, neuromuscular genetics, and new clinical challenges - The Lancet Respiratory Medicine

Frontiers Duchenne muscular dystrophy: disease mechanism and therapeutic strategies

Pharmacological advances for treatment in Duchenne muscular dystrophy - ScienceDirect

Frontiers Current Pharmacological Strategies for Duchenne Muscular Dystrophy

Frontiers Drug development progress in duchenne muscular dystrophy

Role of CRISPR/Cas9 in the treatment of Duchenne muscular dystrophy and its delivery strategies - ScienceDirect